Antibody-drug conjugates (ADCs) represent an exciting and promising therapeutic approach for the treatment of cancers. The US Food and Drug Administration’s recent approval of brentuximab vedotin (...
CITATION STYLE
Beck, A. (2014). Review of Antibody-Drug Conjugates, Methods in Molecular Biology series. MAbs, 6(1), 30–33. https://doi.org/10.4161/mabs.27005
Mendeley helps you to discover research relevant for your work.